A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease

about

A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease

Item

http://www.wikidata.org/entity/Q38872189

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Noninvasive Score Model for ...... nalcoholic Fatty Liver Disease

@en

type

Item

label

A Noninvasive Score Model for ...... nalcoholic Fatty Liver Disease

@en

prefLabel

A Noninvasive Score Model for ...... nalcoholic Fatty Liver Disease

@en

P1476

A Noninvasive Score Model for ...... nalcoholic Fatty Liver Disease

@en

P2093

Fang Liu

http://www.w3.org/2001/XMLSchema#string

Jing Liang

http://www.w3.org/2001/XMLSchema#string

Li Jing

http://www.w3.org/2001/XMLSchema#string

Tao Han

http://www.w3.org/2001/XMLSchema#string

Yingtang Gao

http://www.w3.org/2001/XMLSchema#string

Zhe Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

Global epidemiology of hepatitis B virus

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection.

Global challenges in liver disease.

Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity.

Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.

Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease

P304

8793278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/8793278

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Fengmei Wang

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28349067

http://www.w3.org/2001/XMLSchema#string

P932

5352864

http://www.w3.org/2001/XMLSchema#string